ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
TI
Terasaki Innovation Center at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
Terasaki Innovation Center takes part in 2 sessions at ASHI 2026 in Montréal. Its program centres on how HLA molecules are built and recognized by antibodies. It shows that the bound peptide reshapes HLA antibody specificity, and that a single amino acid change in the DQ alpha chain controls how DQ molecules assemble and are expressed.
| Organization | ASHI 2026 Attendance |
|---|---|
TI Terasaki Innovation Center | |
Nonprofit transplant research center studying how allografts are rejected and developing transplant diagnostics in partnership with Thermo Fisher. | Talk Thu Oct 29 1:55pm–2:10pm Peptide Context Reshapes Human Leukocyte Antigen (HLA) Antibody Specificity HLA antibodies, crossmatching and eplets Poster A Single Amino Acid Polymorphism In Α2 Domain of HLA DQΑ Regulates the Assembly and Expression of HLA DQ Alleles and the Potential Clinical Impact HLA typing, sequencing and genotyping |
Find decision makers at Terasaki Innovation Center
Tell us what you sell and we’ll find the people at Terasaki Innovation Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction